Quantamental Technologies LLC Kura Oncology, Inc. Transaction History
Quantamental Technologies LLC
- $105 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$143 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$141 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$118 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$110 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$92 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.36B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...